| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 77 | 2023 | 892 | 12.970 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 54 | 2020 | 266 | 10.780 |
Why?
|
| Prefrontal Cortex | 30 | 2023 | 639 | 7.530 |
Why?
|
| Toluene | 18 | 2021 | 37 | 6.930 |
Why?
|
| Neurons | 33 | 2023 | 881 | 6.160 |
Why?
|
| Central Nervous System Depressants | 19 | 2018 | 182 | 3.780 |
Why?
|
| Alcoholism | 21 | 2023 | 1109 | 3.510 |
Why?
|
| Solvents | 12 | 2017 | 109 | 3.090 |
Why?
|
| Animals | 129 | 2023 | 20880 | 2.260 |
Why?
|
| Patch-Clamp Techniques | 37 | 2018 | 204 | 2.250 |
Why?
|
| Alcohol Drinking | 11 | 2022 | 805 | 2.020 |
Why?
|
| Glycine | 13 | 2021 | 89 | 1.840 |
Why?
|
| Neuronal Plasticity | 9 | 2020 | 274 | 1.790 |
Why?
|
| Inhalant Abuse | 3 | 2018 | 7 | 1.720 |
Why?
|
| Mice, Inbred C57BL | 26 | 2022 | 2791 | 1.710 |
Why?
|
| Synaptic Transmission | 9 | 2022 | 236 | 1.670 |
Why?
|
| Basolateral Nuclear Complex | 2 | 2023 | 28 | 1.630 |
Why?
|
| Rats | 68 | 2022 | 5300 | 1.610 |
Why?
|
| Cerebral Cortex | 10 | 2018 | 415 | 1.520 |
Why?
|
| Hippocampus | 16 | 2015 | 471 | 1.520 |
Why?
|
| Mice | 46 | 2023 | 8474 | 1.510 |
Why?
|
| N-Methylaspartate | 20 | 2015 | 59 | 1.470 |
Why?
|
| Limbic System | 4 | 2018 | 106 | 1.460 |
Why?
|
| Dose-Response Relationship, Drug | 30 | 2020 | 1745 | 1.430 |
Why?
|
| Recombinant Proteins | 18 | 2013 | 742 | 1.360 |
Why?
|
| Nucleus Accumbens | 4 | 2018 | 417 | 1.350 |
Why?
|
| Synapses | 8 | 2018 | 222 | 1.350 |
Why?
|
| Nerve Tissue Proteins | 4 | 2020 | 290 | 1.340 |
Why?
|
| Brain | 17 | 2020 | 2176 | 1.300 |
Why?
|
| Glutamic Acid | 19 | 2020 | 332 | 1.200 |
Why?
|
| Rats, Sprague-Dawley | 30 | 2022 | 2083 | 1.160 |
Why?
|
| Neurotransmitter Agents | 6 | 2018 | 102 | 1.160 |
Why?
|
| Excitatory Postsynaptic Potentials | 9 | 2020 | 87 | 1.140 |
Why?
|
| Excitatory Amino Acid Antagonists | 14 | 2015 | 128 | 1.100 |
Why?
|
| Long-Term Synaptic Depression | 2 | 2018 | 32 | 1.100 |
Why?
|
| Action Potentials | 11 | 2020 | 223 | 1.090 |
Why?
|
| Endocannabinoids | 3 | 2021 | 32 | 1.060 |
Why?
|
| Receptor, Cannabinoid, CB1 | 6 | 2021 | 68 | 1.040 |
Why?
|
| Neural Inhibition | 5 | 2018 | 80 | 1.010 |
Why?
|
| Membrane Potentials | 20 | 2018 | 200 | 0.990 |
Why?
|
| Oocytes | 12 | 2008 | 57 | 0.980 |
Why?
|
| Dopamine | 20 | 1996 | 474 | 0.960 |
Why?
|
| Male | 68 | 2023 | 37283 | 0.940 |
Why?
|
| Reward | 4 | 2021 | 201 | 0.930 |
Why?
|
| Calcium | 23 | 2010 | 929 | 0.910 |
Why?
|
| Corpus Striatum | 16 | 1997 | 278 | 0.910 |
Why?
|
| Organ Culture Techniques | 9 | 2021 | 122 | 0.880 |
Why?
|
| Receptors, Dopamine D1 | 3 | 2021 | 87 | 0.880 |
Why?
|
| Cell Line | 20 | 2013 | 1752 | 0.880 |
Why?
|
| Mutation | 9 | 2018 | 1213 | 0.840 |
Why?
|
| Central Amygdaloid Nucleus | 1 | 2022 | 16 | 0.840 |
Why?
|
| HEK293 Cells | 8 | 2018 | 326 | 0.830 |
Why?
|
| Transfection | 15 | 2018 | 782 | 0.830 |
Why?
|
| Cannabinoid Receptor Antagonists | 1 | 2021 | 10 | 0.800 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2021 | 5 | 0.780 |
Why?
|
| Morpholines | 6 | 2018 | 79 | 0.770 |
Why?
|
| Cerebellum | 2 | 2020 | 103 | 0.750 |
Why?
|
| Norepinephrine | 9 | 1997 | 276 | 0.740 |
Why?
|
| Calcium Channels | 4 | 2005 | 59 | 0.730 |
Why?
|
| Receptors, Glycine | 3 | 2022 | 9 | 0.730 |
Why?
|
| Pyramidal Cells | 5 | 2018 | 79 | 0.720 |
Why?
|
| Astrocytes | 2 | 2021 | 270 | 0.720 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 35 | 0.710 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 27 | 0.700 |
Why?
|
| Decision Making | 2 | 2021 | 410 | 0.690 |
Why?
|
| Conditioning, Operant | 3 | 2018 | 241 | 0.690 |
Why?
|
| Motor Activity | 2 | 2013 | 621 | 0.660 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 2 | 2017 | 8 | 0.650 |
Why?
|
| Ion Channel Gating | 3 | 2015 | 42 | 0.650 |
Why?
|
| Benzoxazines | 4 | 2018 | 20 | 0.650 |
Why?
|
| Naphthalenes | 4 | 2018 | 47 | 0.640 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2022 | 208 | 0.640 |
Why?
|
| Channelrhodopsins | 1 | 2018 | 7 | 0.630 |
Why?
|
| Biogenic Monoamines | 1 | 2018 | 18 | 0.630 |
Why?
|
| Membrane Transport Modulators | 1 | 2018 | 23 | 0.630 |
Why?
|
| Risk-Taking | 1 | 2019 | 210 | 0.620 |
Why?
|
| Receptors, Cannabinoid | 2 | 2021 | 26 | 0.610 |
Why?
|
| Magnesium | 5 | 2018 | 110 | 0.610 |
Why?
|
| In Vitro Techniques | 15 | 2015 | 765 | 0.590 |
Why?
|
| Receptors, Biogenic Amine | 1 | 2017 | 4 | 0.580 |
Why?
|
| Dopaminergic Neurons | 3 | 2018 | 46 | 0.570 |
Why?
|
| Drug Tolerance | 3 | 2012 | 80 | 0.560 |
Why?
|
| Piperidines | 9 | 2018 | 123 | 0.560 |
Why?
|
| Tryptophan | 1 | 2016 | 65 | 0.550 |
Why?
|
| Carrier Proteins | 4 | 2015 | 597 | 0.550 |
Why?
|
| Calcium Signaling | 2 | 2019 | 97 | 0.550 |
Why?
|
| Protein Subunits | 7 | 2015 | 99 | 0.540 |
Why?
|
| Reinforcement Schedule | 1 | 2016 | 59 | 0.540 |
Why?
|
| Synaptosomes | 11 | 1990 | 57 | 0.540 |
Why?
|
| Cognition | 2 | 2017 | 512 | 0.520 |
Why?
|
| Learning | 1 | 2017 | 186 | 0.520 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 167 | 0.510 |
Why?
|
| Electric Stimulation | 9 | 2015 | 218 | 0.500 |
Why?
|
| Substance Withdrawal Syndrome | 6 | 2022 | 435 | 0.500 |
Why?
|
| Receptors, GABA-A | 2 | 2022 | 89 | 0.500 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 4 | 2017 | 27 | 0.490 |
Why?
|
| Cells, Cultured | 15 | 2015 | 2673 | 0.480 |
Why?
|
| Zinc | 3 | 2005 | 73 | 0.470 |
Why?
|
| Substance-Related Disorders | 4 | 2016 | 1242 | 0.470 |
Why?
|
| Electrophysiology | 8 | 2013 | 160 | 0.460 |
Why?
|
| Cannabinoids | 2 | 2012 | 90 | 0.460 |
Why?
|
| Receptors, Purinergic P2 | 4 | 2008 | 10 | 0.460 |
Why?
|
| Humans | 52 | 2018 | 68549 | 0.450 |
Why?
|
| Sleep, REM | 1 | 2014 | 93 | 0.450 |
Why?
|
| Ventral Tegmental Area | 5 | 2018 | 74 | 0.450 |
Why?
|
| Behavior, Animal | 6 | 2014 | 470 | 0.440 |
Why?
|
| Nitric Oxide | 4 | 2002 | 382 | 0.430 |
Why?
|
| Strychnine | 4 | 2022 | 14 | 0.420 |
Why?
|
| Cannabinoid Receptor Modulators | 1 | 2012 | 16 | 0.410 |
Why?
|
| Tyrosine | 1 | 2013 | 196 | 0.410 |
Why?
|
| Blotting, Western | 7 | 2017 | 954 | 0.410 |
Why?
|
| Reversal Learning | 1 | 2011 | 7 | 0.410 |
Why?
|
| Temperance | 1 | 2011 | 41 | 0.400 |
Why?
|
| Stress, Psychological | 4 | 2020 | 824 | 0.400 |
Why?
|
| Alcohol-Related Disorders | 1 | 2012 | 95 | 0.380 |
Why?
|
| Drug Interactions | 8 | 2013 | 289 | 0.380 |
Why?
|
| Animals, Newborn | 8 | 2011 | 396 | 0.370 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2010 | 93 | 0.370 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 322 | 0.370 |
Why?
|
| Excitatory Amino Acid Agonists | 6 | 2015 | 59 | 0.370 |
Why?
|
| Tissue Culture Techniques | 3 | 2018 | 62 | 0.370 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2020 | 26 | 0.370 |
Why?
|
| Frontal Lobe | 1 | 2011 | 156 | 0.360 |
Why?
|
| Cocaine | 5 | 2018 | 555 | 0.360 |
Why?
|
| Inhibitory Postsynaptic Potentials | 3 | 2017 | 25 | 0.360 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 213 | 0.360 |
Why?
|
| Alcohols | 1 | 2010 | 13 | 0.350 |
Why?
|
| Cysteine | 3 | 2015 | 112 | 0.350 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 411 | 0.350 |
Why?
|
| Amino Acid Substitution | 5 | 2015 | 137 | 0.350 |
Why?
|
| Alternative Splicing | 3 | 2006 | 93 | 0.350 |
Why?
|
| Pyrazoles | 4 | 2018 | 190 | 0.350 |
Why?
|
| Visual Cortex | 2 | 2020 | 67 | 0.340 |
Why?
|
| Female | 22 | 2023 | 38021 | 0.330 |
Why?
|
| Picrotoxin | 2 | 2022 | 14 | 0.320 |
Why?
|
| Ion Channels | 2 | 2005 | 72 | 0.320 |
Why?
|
| Motor Neurons | 3 | 2020 | 98 | 0.320 |
Why?
|
| Cognition Disorders | 1 | 2011 | 342 | 0.320 |
Why?
|
| Brain Injuries | 6 | 2002 | 268 | 0.320 |
Why?
|
| Gene Expression | 4 | 2020 | 770 | 0.310 |
Why?
|
| Phosphorylation | 5 | 2013 | 1200 | 0.300 |
Why?
|
| Morphine | 2 | 2018 | 76 | 0.290 |
Why?
|
| Electric Conductivity | 5 | 2008 | 87 | 0.290 |
Why?
|
| Inhalation Exposure | 2 | 2020 | 33 | 0.280 |
Why?
|
| PC12 Cells | 2 | 2005 | 36 | 0.280 |
Why?
|
| Chelating Agents | 3 | 2003 | 47 | 0.280 |
Why?
|
| src-Family Kinases | 2 | 2004 | 91 | 0.280 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2006 | 8 | 0.280 |
Why?
|
| Swimming | 1 | 2016 | 38 | 0.270 |
Why?
|
| Tetrachloroethylene | 1 | 2005 | 8 | 0.260 |
Why?
|
| Microinjections | 5 | 2018 | 130 | 0.260 |
Why?
|
| Dendritic Spines | 2 | 2017 | 76 | 0.260 |
Why?
|
| Dipeptides | 3 | 2020 | 89 | 0.260 |
Why?
|
| Methamphetamine | 2 | 2018 | 132 | 0.260 |
Why?
|
| Extinction, Psychological | 2 | 2017 | 240 | 0.260 |
Why?
|
| Trichloroethylene | 1 | 2005 | 41 | 0.250 |
Why?
|
| Impulsive Behavior | 1 | 2016 | 85 | 0.250 |
Why?
|
| Intracellular Membranes | 3 | 2002 | 86 | 0.250 |
Why?
|
| Receptors, Neurotransmitter | 2 | 2018 | 31 | 0.250 |
Why?
|
| Organic Chemicals | 1 | 2005 | 77 | 0.250 |
Why?
|
| Gap Junctions | 1 | 2004 | 29 | 0.250 |
Why?
|
| Calpain | 3 | 2020 | 205 | 0.250 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 108 | 0.240 |
Why?
|
| Drug-Seeking Behavior | 2 | 2018 | 213 | 0.240 |
Why?
|
| Xenopus laevis | 6 | 2008 | 60 | 0.240 |
Why?
|
| Signal Transduction | 5 | 2014 | 2689 | 0.240 |
Why?
|
| DNA, Complementary | 3 | 2011 | 251 | 0.240 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2009 | 204 | 0.230 |
Why?
|
| Rats, Inbred Strains | 12 | 1992 | 532 | 0.230 |
Why?
|
| Receptors, AMPA | 2 | 2015 | 99 | 0.230 |
Why?
|
| Nitric Oxide Synthase | 2 | 2002 | 163 | 0.220 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2015 | 21 | 0.220 |
Why?
|
| Microscopy, Confocal | 2 | 2019 | 337 | 0.220 |
Why?
|
| Chloride Channels | 2 | 2000 | 22 | 0.220 |
Why?
|
| Kynurenic Acid | 3 | 2007 | 26 | 0.220 |
Why?
|
| Analysis of Variance | 6 | 2015 | 1040 | 0.220 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2018 | 124 | 0.210 |
Why?
|
| Neuroprotective Agents | 4 | 2020 | 317 | 0.210 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2022 | 1 | 0.210 |
Why?
|
| Electrophysiological Phenomena | 2 | 2013 | 20 | 0.210 |
Why?
|
| Receptors, Nicotinic | 1 | 2002 | 41 | 0.210 |
Why?
|
| Polyamines | 2 | 1993 | 79 | 0.210 |
Why?
|
| Habenula | 1 | 2022 | 13 | 0.210 |
Why?
|
| Long-Term Potentiation | 2 | 2017 | 53 | 0.210 |
Why?
|
| Calcium Channel Blockers | 3 | 2002 | 137 | 0.200 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2021 | 20 | 0.200 |
Why?
|
| Tetrodotoxin | 3 | 2018 | 26 | 0.200 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1999 | 195 | 0.200 |
Why?
|
| Models, Molecular | 2 | 2015 | 546 | 0.190 |
Why?
|
| Aspartic Acid | 4 | 1996 | 65 | 0.190 |
Why?
|
| Administration, Inhalation | 2 | 2020 | 187 | 0.190 |
Why?
|
| Dopamine Agents | 1 | 2021 | 56 | 0.190 |
Why?
|
| Dentate Gyrus | 1 | 2020 | 13 | 0.190 |
Why?
|
| Bicuculline | 3 | 2013 | 17 | 0.190 |
Why?
|
| Xenopus | 5 | 2005 | 30 | 0.180 |
Why?
|
| Actinin | 1 | 2000 | 9 | 0.180 |
Why?
|
| Apoptosis | 5 | 2020 | 1641 | 0.180 |
Why?
|
| Mice, Knockout | 2 | 2015 | 1692 | 0.180 |
Why?
|
| Microdialysis | 9 | 2002 | 147 | 0.180 |
Why?
|
| Sequence Deletion | 1 | 2000 | 89 | 0.180 |
Why?
|
| Fura-2 | 5 | 2002 | 21 | 0.180 |
Why?
|
| Mollusk Venoms | 2 | 1990 | 2 | 0.180 |
Why?
|
| GABA Antagonists | 2 | 2013 | 22 | 0.170 |
Why?
|
| Receptors, Glutamate | 1 | 1999 | 22 | 0.170 |
Why?
|
| Reference Standards | 2 | 2013 | 115 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2008 | 376 | 0.170 |
Why?
|
| Protein Isoforms | 3 | 2016 | 246 | 0.170 |
Why?
|
| Dizocilpine Maleate | 5 | 2009 | 43 | 0.170 |
Why?
|
| Locomotion | 1 | 2020 | 135 | 0.170 |
Why?
|
| Shab Potassium Channels | 2 | 2009 | 6 | 0.170 |
Why?
|
| Glycoproteins | 1 | 2020 | 238 | 0.160 |
Why?
|
| Central Nervous System | 1 | 1999 | 107 | 0.160 |
Why?
|
| Receptors, Dopamine D2 | 4 | 2015 | 109 | 0.160 |
Why?
|
| Amino Acid Sequence | 2 | 2016 | 1082 | 0.160 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2018 | 24 | 0.160 |
Why?
|
| Coculture Techniques | 2 | 2009 | 147 | 0.160 |
Why?
|
| Cations | 1 | 2018 | 51 | 0.160 |
Why?
|
| Risk | 1 | 2019 | 563 | 0.160 |
Why?
|
| Electric Capacitance | 2 | 2015 | 8 | 0.160 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1174 | 0.150 |
Why?
|
| Aging | 2 | 2018 | 911 | 0.150 |
Why?
|
| Kainic Acid | 2 | 2015 | 44 | 0.150 |
Why?
|
| Serine | 3 | 2010 | 99 | 0.150 |
Why?
|
| Potassium Channels | 1 | 2018 | 55 | 0.150 |
Why?
|
| Interleukins | 1 | 2018 | 79 | 0.150 |
Why?
|
| Gadolinium | 1 | 2018 | 88 | 0.150 |
Why?
|
| Dronabinol | 1 | 2018 | 84 | 0.150 |
Why?
|
| Adaptation, Physiological | 2 | 2017 | 189 | 0.150 |
Why?
|
| Deep Brain Stimulation | 1 | 2018 | 71 | 0.150 |
Why?
|
| Potassium Chloride | 6 | 2002 | 45 | 0.150 |
Why?
|
| Conditioning, Classical | 1 | 2017 | 57 | 0.140 |
Why?
|
| Amino Acid Transport System X-AG | 2 | 2008 | 11 | 0.140 |
Why?
|
| Mice, Mutant Strains | 2 | 2015 | 166 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1033 | 0.140 |
Why?
|
| Receptors, Dopamine | 3 | 2014 | 119 | 0.140 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2017 | 51 | 0.140 |
Why?
|
| Voltage-Gated Sodium Channels | 1 | 2016 | 1 | 0.140 |
Why?
|
| Time Factors | 12 | 2010 | 4655 | 0.140 |
Why?
|
| Egtazic Acid | 4 | 2018 | 29 | 0.140 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 31 | 0.140 |
Why?
|
| Kidney | 3 | 2008 | 945 | 0.140 |
Why?
|
| Adenosine Triphosphate | 4 | 2008 | 314 | 0.140 |
Why?
|
| Neuralgia | 1 | 2016 | 27 | 0.130 |
Why?
|
| Quinolines | 1 | 2016 | 48 | 0.130 |
Why?
|
| Homer Scaffolding Proteins | 1 | 2015 | 24 | 0.130 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 44 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 2550 | 0.130 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 3 | 1990 | 10 | 0.130 |
Why?
|
| Protein Conformation | 2 | 2011 | 362 | 0.130 |
Why?
|
| Kinetics | 5 | 2005 | 1047 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 170 | 0.130 |
Why?
|
| Dopamine Antagonists | 3 | 2007 | 65 | 0.130 |
Why?
|
| Oxygen | 5 | 2001 | 386 | 0.130 |
Why?
|
| Enkephalins | 1 | 2015 | 89 | 0.130 |
Why?
|
| Disulfides | 2 | 2011 | 40 | 0.130 |
Why?
|
| Sex Factors | 1 | 2018 | 1265 | 0.120 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1994 | 12 | 0.120 |
Why?
|
| Protein Precursors | 1 | 2015 | 105 | 0.120 |
Why?
|
| Nicotine | 1 | 2018 | 350 | 0.120 |
Why?
|
| Nifedipine | 2 | 2002 | 40 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 1995 | 81 | 0.120 |
Why?
|
| Cell Membrane | 3 | 2009 | 524 | 0.120 |
Why?
|
| Anesthetics, Local | 1 | 1995 | 83 | 0.120 |
Why?
|
| Glycerides | 1 | 2014 | 18 | 0.120 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 17 | 0.120 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2014 | 17 | 0.120 |
Why?
|
| Glutamates | 1 | 2014 | 41 | 0.120 |
Why?
|
| Potassium | 5 | 1997 | 168 | 0.120 |
Why?
|
| Basal Ganglia | 1 | 2014 | 45 | 0.120 |
Why?
|
| Neocortex | 1 | 2014 | 17 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1663 | 0.120 |
Why?
|
| Sulfhydryl Compounds | 1 | 1994 | 73 | 0.120 |
Why?
|
| Arachidonic Acids | 1 | 2014 | 97 | 0.120 |
Why?
|
| Diamines | 1 | 1993 | 9 | 0.110 |
Why?
|
| Volatilization | 2 | 2005 | 13 | 0.110 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 31 | 0.110 |
Why?
|
| Sleep Deprivation | 1 | 2014 | 81 | 0.110 |
Why?
|
| Glucose | 4 | 1999 | 307 | 0.110 |
Why?
|
| Membrane Glycoproteins | 2 | 1995 | 370 | 0.110 |
Why?
|
| Rats, Wistar | 3 | 2020 | 371 | 0.110 |
Why?
|
| Glycine Agents | 1 | 2013 | 5 | 0.110 |
Why?
|
| Molecular Biology | 2 | 2006 | 31 | 0.110 |
Why?
|
| Stereotaxic Techniques | 1 | 2013 | 35 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2014 | 235 | 0.110 |
Why?
|
| Excitatory Amino Acids | 3 | 1998 | 8 | 0.110 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2013 | 71 | 0.110 |
Why?
|
| Biomarkers | 3 | 2017 | 1593 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 2 | 2004 | 13 | 0.100 |
Why?
|
| Aluminum Compounds | 1 | 1992 | 10 | 0.100 |
Why?
|
| Craniocerebral Trauma | 3 | 1998 | 50 | 0.100 |
Why?
|
| Aluminum | 1 | 1992 | 21 | 0.100 |
Why?
|
| Age Factors | 1 | 2017 | 1860 | 0.100 |
Why?
|
| Carbachol | 1 | 1992 | 34 | 0.100 |
Why?
|
| Fluorides | 1 | 1992 | 15 | 0.100 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1992 | 32 | 0.100 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2011 | 10 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2014 | 323 | 0.100 |
Why?
|
| Phenotype | 1 | 2015 | 946 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 1997 | 498 | 0.100 |
Why?
|
| Biophysics | 1 | 2011 | 41 | 0.100 |
Why?
|
| Arginine | 1 | 2011 | 102 | 0.100 |
Why?
|
| Protein Transport | 2 | 2009 | 280 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 329 | 0.090 |
Why?
|
| Probability | 1 | 2011 | 244 | 0.090 |
Why?
|
| Receptors, Melatonin | 1 | 2010 | 8 | 0.090 |
Why?
|
| Melatonin | 1 | 2010 | 39 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 2010 | 270 | 0.090 |
Why?
|
| Memory, Short-Term | 1 | 2010 | 79 | 0.090 |
Why?
|
| Encephalitis, Viral | 1 | 2009 | 5 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 272 | 0.080 |
Why?
|
| AIDS Dementia Complex | 1 | 2009 | 20 | 0.080 |
Why?
|
| Calcium Channels, L-Type | 1 | 2009 | 34 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2009 | 46 | 0.080 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2009 | 26 | 0.080 |
Why?
|
| Hematoma, Subdural | 3 | 1998 | 19 | 0.080 |
Why?
|
| Interneurons | 1 | 2009 | 70 | 0.080 |
Why?
|
| Dihydropyridines | 1 | 1988 | 13 | 0.080 |
Why?
|
| Executive Function | 1 | 2010 | 106 | 0.080 |
Why?
|
| Cocaine-Related Disorders | 1 | 2014 | 504 | 0.080 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 2008 | 2 | 0.080 |
Why?
|
| Fluorescent Dyes | 4 | 2002 | 191 | 0.080 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2007 | 7 | 0.080 |
Why?
|
| Rats, Long-Evans | 2 | 2022 | 203 | 0.080 |
Why?
|
| Estrogens | 1 | 2009 | 173 | 0.080 |
Why?
|
| Comorbidity | 1 | 2012 | 1425 | 0.080 |
Why?
|
| Sarcosine | 1 | 2007 | 1 | 0.070 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 1 | 2007 | 2 | 0.070 |
Why?
|
| HIV-1 | 1 | 2009 | 177 | 0.070 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2007 | 9 | 0.070 |
Why?
|
| Pyrrolidinones | 1 | 2007 | 15 | 0.070 |
Why?
|
| Alanine | 1 | 2007 | 38 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 626 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 175 | 0.070 |
Why?
|
| Benzazepines | 1 | 2007 | 104 | 0.070 |
Why?
|
| Sodium Channel Blockers | 2 | 2016 | 23 | 0.070 |
Why?
|
| Nicotinic Acids | 1 | 1986 | 5 | 0.070 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2006 | 7 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2006 | 73 | 0.070 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2006 | 6 | 0.070 |
Why?
|
| Anesthetics | 1 | 2006 | 30 | 0.070 |
Why?
|
| Septal Nuclei | 1 | 2006 | 31 | 0.070 |
Why?
|
| Restraint, Physical | 1 | 2016 | 59 | 0.070 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2006 | 75 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 176 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2010 | 718 | 0.070 |
Why?
|
| Calibration | 1 | 2005 | 73 | 0.070 |
Why?
|
| Calmodulin | 2 | 1998 | 53 | 0.060 |
Why?
|
| Retinal Ganglion Cells | 1 | 2006 | 72 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2006 | 223 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 201 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2006 | 108 | 0.060 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2005 | 2 | 0.060 |
Why?
|
| Symporters | 1 | 2005 | 27 | 0.060 |
Why?
|
| Connexins | 1 | 2004 | 35 | 0.060 |
Why?
|
| Models, Psychological | 1 | 2016 | 180 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 214 | 0.060 |
Why?
|
| Amygdala | 1 | 2006 | 159 | 0.060 |
Why?
|
| Immunity, Cellular | 2 | 1994 | 80 | 0.060 |
Why?
|
| Stimulation, Chemical | 3 | 2006 | 57 | 0.060 |
Why?
|
| Thapsigargin | 2 | 2002 | 18 | 0.060 |
Why?
|
| Anesthetics, Inhalation | 2 | 2006 | 21 | 0.060 |
Why?
|
| Edetic Acid | 1 | 2003 | 29 | 0.060 |
Why?
|
| Metals, Heavy | 1 | 2003 | 18 | 0.060 |
Why?
|
| Spinal Cord | 2 | 2020 | 244 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2006 | 682 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 782 | 0.060 |
Why?
|
| Dithionitrobenzoic Acid | 2 | 1994 | 3 | 0.060 |
Why?
|
| Dithiothreitol | 2 | 1994 | 17 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 3 | 1997 | 296 | 0.060 |
Why?
|
| Drug Synergism | 2 | 1995 | 260 | 0.060 |
Why?
|
| Peptides | 1 | 2006 | 455 | 0.050 |
Why?
|
| Depression, Chemical | 1 | 2002 | 29 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2002 | 54 | 0.050 |
Why?
|
| Acetylcholine | 1 | 2002 | 64 | 0.050 |
Why?
|
| Naegleria fowleri | 1 | 2002 | 2 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 35 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 1995 | 511 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 189 | 0.050 |
Why?
|
| Lactic Acid | 2 | 1999 | 86 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 1994 | 567 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 24 | 0.050 |
Why?
|
| Flurothyl | 1 | 2000 | 1 | 0.050 |
Why?
|
| Trichloroethanes | 1 | 2000 | 1 | 0.050 |
Why?
|
| Xylenes | 1 | 2000 | 3 | 0.050 |
Why?
|
| Lactates | 2 | 1997 | 29 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 24 | 0.050 |
Why?
|
| Benzene | 1 | 2000 | 9 | 0.050 |
Why?
|
| Benzene Derivatives | 1 | 2000 | 12 | 0.050 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2001 | 61 | 0.050 |
Why?
|
| Apomorphine | 2 | 1990 | 48 | 0.050 |
Why?
|
| Seizures | 2 | 2008 | 279 | 0.050 |
Why?
|
| Ionomycin | 3 | 2006 | 24 | 0.050 |
Why?
|
| Ionophores | 3 | 2006 | 25 | 0.050 |
Why?
|
| Complement System Proteins | 1 | 2002 | 135 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2000 | 12 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2000 | 57 | 0.050 |
Why?
|
| Calcium Channel Agonists | 2 | 2010 | 18 | 0.040 |
Why?
|
| Orientation | 1 | 2020 | 31 | 0.040 |
Why?
|
| omega-Conotoxin GVIA | 2 | 1990 | 3 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2020 | 102 | 0.040 |
Why?
|
| Cats | 1 | 2020 | 292 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 442 | 0.040 |
Why?
|
| Photic Stimulation | 1 | 2020 | 229 | 0.040 |
Why?
|
| Monitoring, Physiologic | 2 | 1997 | 219 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 250 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 1999 | 27 | 0.040 |
Why?
|
| Enzyme Activation | 3 | 2007 | 791 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1999 | 21 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1999 | 88 | 0.040 |
Why?
|
| Brain Ischemia | 4 | 1998 | 665 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1998 | 27 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2001 | 266 | 0.040 |
Why?
|
| Glycolysis | 1 | 1999 | 79 | 0.040 |
Why?
|
| Receptors, Presynaptic | 1 | 2018 | 6 | 0.040 |
Why?
|
| Gentisates | 1 | 1998 | 1 | 0.040 |
Why?
|
| CD2 Antigens | 2 | 1995 | 8 | 0.040 |
Why?
|
| Culture Media | 1 | 1998 | 155 | 0.040 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2018 | 79 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 499 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 282 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 1446 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 2798 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2018 | 311 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1997 | 618 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2001 | 458 | 0.040 |
Why?
|
| 4-Aminopyridine | 1 | 1997 | 5 | 0.040 |
Why?
|
| Receptors, Purinergic P2X3 | 2 | 2008 | 2 | 0.040 |
Why?
|
| Sodium | 2 | 1988 | 161 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2017 | 31 | 0.040 |
Why?
|
| Stereotyped Behavior | 3 | 1993 | 42 | 0.040 |
Why?
|
| Drug Combinations | 1 | 1997 | 304 | 0.040 |
Why?
|
| Membranes | 1 | 1996 | 26 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2009 | 233 | 0.040 |
Why?
|
| Paroxetine | 1 | 1996 | 28 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1997 | 137 | 0.040 |
Why?
|
| Antigens, CD | 2 | 1994 | 230 | 0.040 |
Why?
|
| Pyrroles | 2 | 2009 | 83 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 1995 | 397 | 0.030 |
Why?
|
| Cricetulus | 1 | 2016 | 98 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2001 | 902 | 0.030 |
Why?
|
| CHO Cells | 1 | 2016 | 161 | 0.030 |
Why?
|
| Cricetinae | 1 | 2016 | 262 | 0.030 |
Why?
|
| Cytochromes c | 2 | 2006 | 75 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2006 | 111 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2016 | 1329 | 0.030 |
Why?
|
| Aminobenzoates | 1 | 1995 | 2 | 0.030 |
Why?
|
| Procaine | 1 | 1995 | 9 | 0.030 |
Why?
|
| Caspases | 2 | 2006 | 194 | 0.030 |
Why?
|
| Apamin | 1 | 2015 | 13 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2006 | 174 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2015 | 32 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1995 | 165 | 0.030 |
Why?
|
| Lidocaine | 1 | 1995 | 36 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 35 | 0.030 |
Why?
|
| Pyrimidines | 1 | 1996 | 178 | 0.030 |
Why?
|
| Ferrocyanides | 1 | 1994 | 2 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 1995 | 58 | 0.030 |
Why?
|
| Adolescent | 2 | 2016 | 8904 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 10 | 0.030 |
Why?
|
| Models, Biological | 3 | 2006 | 981 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 63 | 0.030 |
Why?
|
| Piperazines | 1 | 1996 | 206 | 0.030 |
Why?
|
| Propanolamines | 1 | 1995 | 70 | 0.030 |
Why?
|
| Child | 1 | 2016 | 6401 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 1994 | 49 | 0.030 |
Why?
|
| Immunoconjugates | 1 | 1994 | 26 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1995 | 182 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 1994 | 99 | 0.030 |
Why?
|
| Hemodynamics | 1 | 1997 | 705 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1991 | 134 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 1995 | 82 | 0.030 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1994 | 27 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2015 | 85 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 234 | 0.030 |
Why?
|
| Carotid Stenosis | 1 | 1995 | 163 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 420 | 0.030 |
Why?
|
| Oxidopamine | 1 | 1993 | 42 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 1994 | 72 | 0.030 |
Why?
|
| Extracellular Space | 2 | 2007 | 121 | 0.030 |
Why?
|
| Neostriatum | 1 | 1993 | 60 | 0.030 |
Why?
|
| Liver | 1 | 1999 | 1118 | 0.030 |
Why?
|
| Intracranial Pressure | 3 | 1998 | 58 | 0.030 |
Why?
|
| Computational Biology | 1 | 2015 | 190 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 521 | 0.030 |
Why?
|
| Benzofurans | 2 | 1989 | 21 | 0.030 |
Why?
|
| Software | 1 | 1995 | 418 | 0.030 |
Why?
|
| Biguanides | 1 | 1991 | 4 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 689 | 0.030 |
Why?
|
| Graft Survival | 1 | 1994 | 465 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1991 | 49 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 948 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1995 | 597 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 231 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1992 | 141 | 0.020 |
Why?
|
| Propidium | 1 | 2010 | 26 | 0.020 |
Why?
|
| Mitochondria | 2 | 2006 | 643 | 0.020 |
Why?
|
| Nitrendipine | 1 | 1990 | 8 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1990 | 65 | 0.020 |
Why?
|
| Valine | 1 | 1990 | 43 | 0.020 |
Why?
|
| Tryptamines | 1 | 2010 | 7 | 0.020 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2010 | 11 | 0.020 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2010 | 22 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2010 | 40 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1989 | 13 | 0.020 |
Why?
|
| Microsomes | 1 | 1989 | 31 | 0.020 |
Why?
|
| Partial Pressure | 2 | 2001 | 19 | 0.020 |
Why?
|
| Inflammation | 1 | 2016 | 1030 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2010 | 128 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2010 | 93 | 0.020 |
Why?
|
| Cues | 1 | 2014 | 654 | 0.020 |
Why?
|
| Cytosol | 1 | 1989 | 123 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 3 | 1995 | 532 | 0.020 |
Why?
|
| Cell Physiological Phenomena | 1 | 2009 | 19 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 168 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 42 | 0.020 |
Why?
|
| Glasgow Coma Scale | 2 | 1999 | 65 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1988 | 36 | 0.020 |
Why?
|
| Pentylenetetrazole | 1 | 2008 | 10 | 0.020 |
Why?
|
| Maze Learning | 1 | 2009 | 138 | 0.020 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2008 | 15 | 0.020 |
Why?
|
| Receptors, Purinergic P2X2 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2009 | 238 | 0.020 |
Why?
|
| Ventriculostomy | 2 | 1998 | 7 | 0.020 |
Why?
|
| Gliosis | 1 | 1988 | 51 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 1988 | 86 | 0.020 |
Why?
|
| Antibodies | 1 | 2009 | 241 | 0.020 |
Why?
|
| Estradiol | 1 | 2009 | 176 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 39 | 0.020 |
Why?
|
| Phenols | 1 | 2007 | 73 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2007 | 78 | 0.020 |
Why?
|
| Carbon Dioxide | 2 | 1997 | 78 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2009 | 201 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 216 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1988 | 183 | 0.020 |
Why?
|
| Hypoxia, Brain | 2 | 1997 | 16 | 0.020 |
Why?
|
| Imipramine | 1 | 1986 | 44 | 0.020 |
Why?
|
| Nimodipine | 1 | 1986 | 5 | 0.020 |
Why?
|
| Receptors, Purinergic P2X | 1 | 2006 | 2 | 0.020 |
Why?
|
| Anesthetics, Intravenous | 1 | 2006 | 27 | 0.020 |
Why?
|
| Acute Disease | 2 | 1998 | 658 | 0.020 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Spectrin | 1 | 2005 | 17 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2005 | 23 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2005 | 73 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2006 | 241 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1293 | 0.020 |
Why?
|
| Synapsins | 1 | 2004 | 11 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 226 | 0.020 |
Why?
|
| Dendrites | 1 | 2004 | 44 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2005 | 109 | 0.020 |
Why?
|
| Carbazoles | 1 | 2004 | 46 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2008 | 617 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1994 | 79 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 1995 | 489 | 0.010 |
Why?
|
| Indoles | 1 | 2004 | 146 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1998 | 381 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 1997 | 1465 | 0.010 |
Why?
|
| Ion Transport | 1 | 2002 | 26 | 0.010 |
Why?
|
| Manganese | 1 | 2002 | 26 | 0.010 |
Why?
|
| Nitrites | 1 | 2001 | 53 | 0.010 |
Why?
|
| Nitrates | 1 | 2001 | 61 | 0.010 |
Why?
|
| Injections | 2 | 1993 | 119 | 0.010 |
Why?
|
| Tunica Intima | 1 | 2001 | 59 | 0.010 |
Why?
|
| Adult | 4 | 2001 | 21379 | 0.010 |
Why?
|
| Complement Activation | 1 | 2002 | 145 | 0.010 |
Why?
|
| Salmon | 1 | 1980 | 9 | 0.010 |
Why?
|
| Hydrostatic Pressure | 1 | 1980 | 11 | 0.010 |
Why?
|
| Chromones | 1 | 2000 | 33 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2000 | 38 | 0.010 |
Why?
|
| Cytokines | 2 | 1995 | 866 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2000 | 61 | 0.010 |
Why?
|
| Androstadienes | 1 | 2000 | 41 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2000 | 138 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 140 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 134 | 0.010 |
Why?
|
| Models, Animal | 1 | 2001 | 252 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1980 | 123 | 0.010 |
Why?
|
| Flavonoids | 1 | 2000 | 109 | 0.010 |
Why?
|
| Pressure | 1 | 1980 | 252 | 0.010 |
Why?
|
| Imidazoles | 1 | 2000 | 175 | 0.010 |
Why?
|
| Aorta | 1 | 2001 | 316 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2000 | 223 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2000 | 312 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 852 | 0.010 |
Why?
|
| Cell Size | 1 | 1998 | 76 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 1998 | 34 | 0.010 |
Why?
|
| Exocytosis | 1 | 1998 | 34 | 0.010 |
Why?
|
| Oxyhemoglobins | 1 | 1998 | 3 | 0.010 |
Why?
|
| Hydroxybenzoates | 1 | 1998 | 9 | 0.010 |
Why?
|
| Brain Concussion | 1 | 1998 | 27 | 0.010 |
Why?
|
| Pyridines | 1 | 2000 | 261 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1998 | 41 | 0.010 |
Why?
|
| Free Radicals | 1 | 1998 | 65 | 0.010 |
Why?
|
| Amino Acids | 1 | 1998 | 131 | 0.010 |
Why?
|
| Intracranial Hypertension | 1 | 1998 | 53 | 0.010 |
Why?
|
| Molecular Probe Techniques | 1 | 1997 | 7 | 0.010 |
Why?
|
| Cell Death | 1 | 1998 | 329 | 0.010 |
Why?
|
| Hyperventilation | 1 | 1997 | 6 | 0.010 |
Why?
|
| Brain Death | 1 | 1997 | 34 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1997 | 10 | 0.010 |
Why?
|
| Microelectrodes | 1 | 1997 | 16 | 0.010 |
Why?
|
| Hypercapnia | 1 | 1997 | 17 | 0.010 |
Why?
|
| Respiration | 1 | 1997 | 91 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 659 | 0.010 |
Why?
|
| Homeostasis | 1 | 1998 | 291 | 0.010 |
Why?
|
| Body Temperature | 1 | 1997 | 116 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1997 | 173 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1997 | 2324 | 0.010 |
Why?
|
| Dialysis | 1 | 1996 | 30 | 0.010 |
Why?
|
| Threonine | 1 | 1996 | 47 | 0.010 |
Why?
|
| Hypoxia | 1 | 1997 | 169 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 1998 | 7028 | 0.010 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 1995 | 5 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 1851 | 0.010 |
Why?
|
| CD11 Antigens | 1 | 1995 | 2 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1995 | 5 | 0.010 |
Why?
|
| CD18 Antigens | 1 | 1995 | 9 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1997 | 222 | 0.010 |
Why?
|
| CD3 Complex | 1 | 1995 | 35 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 1995 | 85 | 0.010 |
Why?
|
| Leukocyte Common Antigens | 1 | 1995 | 41 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 1995 | 42 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1994 | 9 | 0.010 |
Why?
|
| Dermatitis, Contact | 1 | 1994 | 14 | 0.010 |
Why?
|
| Abatacept | 1 | 1994 | 17 | 0.010 |
Why?
|
| CTLA-4 Antigen | 1 | 1994 | 45 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1994 | 107 | 0.010 |
Why?
|
| CD48 Antigen | 1 | 1994 | 2 | 0.010 |
Why?
|
| Contact Inhibition | 1 | 1994 | 2 | 0.010 |
Why?
|
| CD58 Antigens | 1 | 1994 | 4 | 0.010 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 1994 | 11 | 0.010 |
Why?
|
| Spleen | 1 | 1995 | 301 | 0.010 |
Why?
|
| Epitopes | 1 | 1994 | 146 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1994 | 66 | 0.010 |
Why?
|
| Medial Forebrain Bundle | 1 | 1993 | 3 | 0.010 |
Why?
|
| Hyaluronan Receptors | 1 | 1995 | 142 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 248 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1994 | 215 | 0.010 |
Why?
|
| Rotation | 1 | 1993 | 58 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 1993 | 64 | 0.010 |
Why?
|
| Ligands | 1 | 1994 | 317 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1994 | 328 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1997 | 1449 | 0.010 |
Why?
|
| Middle Aged | 2 | 2001 | 21119 | 0.010 |
Why?
|
| Rest | 1 | 1989 | 78 | 0.010 |
Why?
|
| Electrochemistry | 1 | 1989 | 70 | 0.010 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 1988 | 1 | 0.010 |
Why?
|
| Cell Count | 1 | 1988 | 248 | 0.000 |
Why?
|
| Clomipramine | 1 | 1986 | 8 | 0.000 |
Why?
|
| Desipramine | 1 | 1986 | 47 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1986 | 136 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1986 | 282 | 0.000 |
Why?
|
| Serotonin | 1 | 1986 | 144 | 0.000 |
Why?
|
| Aged | 1 | 2001 | 14842 | 0.000 |
Why?
|
| Binding Sites | 1 | 1986 | 631 | 0.000 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 1980 | 4 | 0.000 |
Why?
|
| Blood Cell Count | 1 | 1980 | 35 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1980 | 87 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1980 | 284 | 0.000 |
Why?
|